Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network

Peritoneal dialysis (PD) therapy substantially requires biomarkers as tools to identify patients who are at the highest risk for PD-related complications and to guide personalized interventions that may improve clinical outcome in the individual patient. In this consensus article, members of the Eur...

Full description

Saved in:
Bibliographic Details
Main Authors: Aufricht, Christoph (Author) , Schmitt, Claus P. (Author)
Format: Article (Journal)
Language:English
Published: 8 August 2017
In: Kidney international
Year: 2017, Volume: 92, Issue: 4, Pages: 824-835
ISSN:1523-1755
DOI:10.1016/j.kint.2017.02.037
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.kint.2017.02.037
Get full text
Author Notes:Christoph Aufricht, Robert Beelen, Matthias Eberl, Michel Fischbach, Donald Fraser, Achim Jörres, Klaus Kratochwill, Manuel LópezCabrera, Peter Rutherford, Claus-Peter Schmitt, Nicholas Topley, Janusz Witowski

MARC

LEADER 00000caa a2200000 c 4500
001 1580441696
003 DE-627
005 20240316100514.0
007 cr uuu---uuuuu
008 180828s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.kint.2017.02.037  |2 doi 
035 |a (DE-627)1580441696 
035 |a (DE-576)510441696 
035 |a (DE-599)BSZ510441696 
035 |a (OCoLC)1341017696 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Aufricht, Christoph  |d 1963-  |e VerfasserIn  |0 (DE-588)1024919935  |0 (DE-627)720772877  |0 (DE-576)369686772  |4 aut 
245 1 0 |a Biomarker research to improve clinical outcomes of peritoneal dialysis  |b consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network  |c Christoph Aufricht, Robert Beelen, Matthias Eberl, Michel Fischbach, Donald Fraser, Achim Jörres, Klaus Kratochwill, Manuel LópezCabrera, Peter Rutherford, Claus-Peter Schmitt, Nicholas Topley, Janusz Witowski 
264 1 |c 8 August 2017 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 8 August 2017 
500 |a Gesehen am 28.08.2018 
520 |a Peritoneal dialysis (PD) therapy substantially requires biomarkers as tools to identify patients who are at the highest risk for PD-related complications and to guide personalized interventions that may improve clinical outcome in the individual patient. In this consensus article, members of the European Training and Research in Peritoneal Dialysis Network (EuTRiPD) review the current status of biomarker research in PD and suggest a selection of biomarkers that can be relevant to the care of PD patients and that are directly accessible in PD effluents. Currently used biomarkers such as interleukin-6, interleukin-8, ex vivo-stimulated interleukin-6 release, cancer antigen-125, and advanced oxidation protein products that were collected through a Delphi procedure were first triaged for inclusion as surrogate endpoints in a clinical trial. Next, novel biomarkers were selected as promising candidates for proof-of-concept studies and were differentiated into inflammation signatures (including interleukin-17, M1/M2 macrophages, and regulatory T cell/T helper 17), mesothelial-to-mesenchymal transition signatures (including microRNA-21 and microRNA-31), and signatures for senescence and inadequate cellular stress responses. Finally, the need for defining pathogen-specific immune fingerprints and phenotype-associated molecular signatures utilizing effluents from the clinical cohorts of PD patients and "omics" technologies and bioinformatics-biostatistics in future joint-research efforts was expressed. Biomarker research in PD offers the potential to develop valuable tools for improving patient management. However, for all biomarkers discussed in this consensus article, the association of biological rationales with relevant clinical outcomes remains to be rigorously validated in adequately powered, prospective, independent clinical studies. 
650 4 |a Biomarkers 
650 4 |a Biomedical Research 
650 4 |a Consensus 
650 4 |a Dialysis Solutions 
650 4 |a epithelial-mesenchymal transition 
650 4 |a Humans 
650 4 |a Kidney Failure, Chronic 
650 4 |a Nephrologists 
650 4 |a Peritoneal Dialysis 
650 4 |a Peritoneum 
650 4 |a peritonitis 
650 4 |a Peritonitis 
650 4 |a Practice Guidelines as Topic 
650 4 |a Precision Medicine 
650 4 |a proteomics 
650 4 |a Proteomics 
650 4 |a renal replacement therapy 
650 4 |a surrogate markers 
650 4 |a ultrafiltration failure 
700 1 |a Schmitt, Claus P.  |e VerfasserIn  |0 (DE-588)1030179123  |0 (DE-627)734893620  |0 (DE-576)377990280  |4 aut 
773 0 8 |i Enthalten in  |t Kidney international  |d New York, NY : Elsevier, 1972  |g 92(2017), 4, Seite 824-835  |h Online-Ressource  |w (DE-627)32046637X  |w (DE-600)2007940-0  |w (DE-576)091143004  |x 1523-1755  |7 nnas  |a Biomarker research to improve clinical outcomes of peritoneal dialysis consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network 
773 1 8 |g volume:92  |g year:2017  |g number:4  |g pages:824-835  |g extent:12  |a Biomarker research to improve clinical outcomes of peritoneal dialysis consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network 
856 4 0 |u http://dx.doi.org/10.1016/j.kint.2017.02.037  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20180828 
993 |a Article 
994 |a 2017 
998 |g 1030179123  |a Schmitt, Claus P.  |m 1030179123:Schmitt, Claus P.  |d 910000  |d 910500  |e 910000PS1030179123  |e 910500PS1030179123  |k 0/910000/  |k 1/910000/910500/  |p 10 
999 |a KXP-PPN1580441696  |e 3024040404 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"Biomarker research to improve clinical outcomes of peritoneal dialysis consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) networkKidney international","origin":[{"publisher":"Elsevier ; Blackwell ; Wiley-Blackwell ; Nature Publishing Group","dateIssuedDisp":"1972-","publisherPlace":"New York, NY ; Oxford [u.a.] ; [Erscheinungsort nicht ermittelbar] ; Basingstoke","dateIssuedKey":"1972"}],"corporate":[{"display":"International Society of Nephrology","role":"isb"}],"id":{"zdb":["2007940-0"],"eki":["32046637X"],"issn":["1523-1755"]},"recId":"32046637X","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 20.08.20"],"pubHistory":["1.1972 -"],"language":["eng"],"part":{"volume":"92","text":"92(2017), 4, Seite 824-835","extent":"12","issue":"4","pages":"824-835","year":"2017"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Kidney international","subtitle":"official journal of the International Society of Nephrology","title_sort":"Kidney international"}]}],"title":[{"subtitle":"consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network","title_sort":"Biomarker research to improve clinical outcomes of peritoneal dialysis","title":"Biomarker research to improve clinical outcomes of peritoneal dialysis"}],"physDesc":[{"extent":"12 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1580441696","id":{"doi":["10.1016/j.kint.2017.02.037"],"eki":["1580441696"]},"origin":[{"dateIssuedDisp":"8 August 2017","dateIssuedKey":"2017"}],"name":{"displayForm":["Christoph Aufricht, Robert Beelen, Matthias Eberl, Michel Fischbach, Donald Fraser, Achim Jörres, Klaus Kratochwill, Manuel LópezCabrera, Peter Rutherford, Claus-Peter Schmitt, Nicholas Topley, Janusz Witowski"]},"language":["eng"],"note":["Available online 8 August 2017","Gesehen am 28.08.2018"],"person":[{"family":"Aufricht","role":"aut","display":"Aufricht, Christoph","given":"Christoph"},{"display":"Schmitt, Claus P.","family":"Schmitt","role":"aut","given":"Claus P."}]} 
SRT |a AUFRICHTCHBIOMARKERR8201